Financial and HR benchmarking of a cancer immunotherapy company

Challenge A well-capitalized cancer immunotherapy company, operating in a highly competitive field, needed to benchmark its financial status and staff numbers against its peers to help gauge its...
Learn More

Strategic and operational support for a start-up oncology company

Challenge A start-up company was planning to license an immunomodulatory product from a European pharmaceutical company. The therapy had been unsuccessfully tried in allergic disorders, but the...
Learn More

Valuation of a first in class, clinical stage small molecule to treat a range of tumor types

Challenge A private biotech company was preparing for an IPO. The company was developing a first-in-class small molecule inhibitor with the potential to treat a range of tumor types. The company was...
Learn More

Valuation and Partnering Support

Challenge A biotech company engaged in licensing discussions with a number of major pharma companies needed help with risk adjusted NPV (rNPV) valuations for each program.
Learn More

Monetizing oncology royalty streams

Challenge A licensor of a marketed oncology drug needed support with monetizing its royalty stream. Alacrita was engaged to develop an independent market-based valuation of the product.
Learn More

Valuation modelling of front-loaded vs. risk sharing deal for drug discovery collaboration

Challenge A drug discovery company was in discussions with a big pharma about collaborating on a number of strategies that would deliver at least one quality clinical candidate. The pharma company...
Learn More

Helping an oncology company with a preclinical project to seek finance and potential acquisition

Challenge A virtual life science company had raised money from angel investors and anticipated a clinical development strategy for their product targeting two major cancer indications. The client...
Learn More

Matching sellers with buyers for a wound care product

Challenge A company developing a novel wound care product was embarking on a significant clinical trial program. It was planning an investor exit in the next 24 months and therefore wanted to connect...
Learn More

Providing business development and deal support in antibiotics

Challenge A pharma company that specializes in discovering and developing antibiotics asked us to help expand the search for a development partner in some of its drug candidates.
Learn More

Valuing a cancer immunotherapy asset

Challenge A biotech company developing a cell-based cancer immunotherapy was engaged in licensing discussions with a number of major pharma companies and needed valuation support.
Learn More

Valuing multinational pharma company partnerships

Challenge A division of a multinational pharma company needed to evaluate a pipeline agreement with an antibody platform technology company. They wished to understand the overall value of the...
Learn More

Supporting a biotech company’s pharma partnerships

Challenge A biotech company needed support with an active partnering process with several major pharma companies.
Learn More
Content not found